Search

Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective

Journal: Current Neurovascular Research
Volume: 2 Issue: 4 Year: 2005 Page: 349-362
Author(s): D. S. Skundric

Relapsing Remitting Multiple Sclerosis and its Relationship with the Immune System and Oxidative Stress

Journal: Current Immunology Reviews (Discontinued)
Volume: 14 Issue: 1 Year: 2018 Page: 15-23
Author(s): Ada Paloma Soto-Brambila,Genaro Gabriel Ortiz,Paloma Rivero-Moragrega,Ana Laura Briones-Torres,Luis Javier Gonzalez-Ortiz,Fermin Paul Pacheco-Moises

Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

Journal: Reviews on Recent Clinical Trials
Volume: 5 Issue: 3 Year: 2010 Page: 179-188
Author(s): James J. Marriott, Paul W. OConnor

An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4475-4484
Author(s): Brigitte K. Paap,Alexander Hundeshagen,Michael Hecker,Uwe K. Zettl

The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

Journal: Current Neuropharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 256-268
Author(s): Pawel Kawalec,Alicja Mikrut,Natalia Wisniewska,Andrzej Pilc

An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14 Issue: 6 Year: 2015 Page: 804-810
Author(s): Rodica Balasa,Smaranda Maier,Septimiu Voidazan,Adina Hutanu,Zoltan Bajko,Anca Motataianu

Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 3 Year: 2016 Page: 4876-4880
Author(s): Begona M. Escribano, Macarena Aguilar-Luque, Carmen Bahamonde, Cristina Conde, Rafael Lillo, Fernando Sanchez-Lopez, Ana I. Giraldo, Antonio H. Cruz, Evelio Luque, Felix Gascon, Eduardo Aguera, Isaac Tunez

Clinical Trials in Relapsing-Remitting Multiple Sclerosis /A New Proposal for Dealing with Basic Problems and Restrictions/

Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 3 Year: 2011 Page: 256-258
Author(s): Mieczyslaw Wender, Grazyna Michalowska-Wender

Journal: Current Neuropharmacology
Volume: 8 Issue: 3 Year: 2010 Page: 305-315
Author(s): Dirk Fitzner, Mikael Simons

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2009 Page: 4858-4868
Author(s): F. Di Pauli, T. Berger, M. Reindl